India’s TB strategy may drive the creation of user-friendly medical devices

The mycobacterium tuberculosis tests market’s annual CAGR to grow by 4%.

India’s tuberculosis management strategy is its patient-centric approach, which will prompt the creation of user-friendly and accessible medical devices for TB diagnosis and monitoring, GlobalData said.

“As TB management expands beyond healthcare centres to community settings, the need for medical devices that can be deployed in mobile medical vans, such as the ‘TB-Mukt Express,’ becomes apparent,” read the study. 

Some of India’s strategies to fight tuberculosis are community engagement and active case finding.

“Opportunities may arise for medical device companies to design solutions specifically suited for use in community health settings. These devices can aid healthcare workers in the early detection and intervention, further enhancing the fight against tuberculosis,” it added.

The mycobacterium tuberculosis tests market’s annual CAGR may increase by 4% between 2023 to 2033.